Page last updated: 2024-08-26

mci 9038 and Animal Mammary Carcinoma

mci 9038 has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Katib, W; Allan, AL; Chambers, AF; Goodale, D; Hedley, BD; Postenka, CO; Schulze, EB; Tuck, AB	1

Other Studies

1 other study(ies) available for mci 9038 and Animal Mammary Carcinoma

Article	Year
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms. Breast cancer research and treatment, 2008, Volume: 112, Issue:2 Topics: Animals; Anticoagulants; Arginine; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Female; Humans; Mammary Neoplasms, Animal; Mice; Neoplasm Metastasis; Osteopontin; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptors, Thrombin; Sulfonamides; Thrombin	2008

Article

Year

The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.

Breast cancer research and treatment, 2008, Volume: 112, Issue:2

Topics: Animals; Anticoagulants; Arginine; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Female; Humans; Mammary Neoplasms, Animal; Mice; Neoplasm Metastasis; Osteopontin; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptors, Thrombin; Sulfonamides; Thrombin

2008